DocGo’s (DCGO) Buy Rating Reiterated at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reaffirmed by research analysts at Needham & Company LLC in a report issued on Wednesday, Benzinga reports.

A number of other equities analysts have also issued reports on the company. Canaccord Genuity Group reaffirmed a “hold” rating and set a $1.00 price target on shares of DocGo in a research note on Tuesday, August 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $2.38.

DocGo Stock Up 12.0%

NASDAQ DCGO traded up $0.04 on Wednesday, reaching $0.41. 394,495 shares of the stock traded hands, compared to its average volume of 881,300. The firm’s fifty day simple moving average is $0.48 and its 200 day simple moving average is $0.56. The company has a market cap of $40.76 million, a price-to-earnings ratio of -0.21 and a beta of 0.94. DocGo has a 12 month low of $0.31 and a 12 month high of $1.65.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The firm had revenue of $73.42 million for the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. As a group, equities research analysts forecast that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Investors Weigh In On DocGo

Several large investors have recently modified their holdings of the stock. S Squared Technology LLC acquired a new stake in DocGo during the second quarter valued at $1,060,725. BlackRock Inc. acquired a new stake in DocGo during the second quarter valued at $750,000. GSA Capital Partners LLP acquired a new stake in DocGo during the second quarter valued at $517,000. Renaissance Technologies LLC boosted its position in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after purchasing an additional 944,826 shares during the last quarter. Finally, Marquette Asset Management LLC acquired a new stake in DocGo during the second quarter valued at $175,000. 56.44% of the stock is owned by institutional investors.

DocGo Company Profile

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.